STROKE-INTRA ARTERIAL THROMBOLYTIC THERAPY

SUMMARY

1. Intra-arterial fibrinolysis is beneficial for carefully selected patients with major ischemic strokes < 6 hours caused by occlusion of the MCA who are not candidates for IV fibrinolytics.

2. Reasonable in patients who have contraindications to use of IV fibrinolytics.

3. Reasonable as rescue therapy in patients with large occlusions who have not responded to IV fibrinolytics.

Reference(s)

Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].